ArticleTherapeutic advances in hematology2012

Alemtuzumab use in relapsed and refractory chronic lymphocytic leukemia: a history and discussion of future rational use.

Jeremy L Warner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.